Related Experiment Video
Updated: Jun 26, 2026
09:10
An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
Published on: November 15, 2024
Intensity-modulated radiation therapy for orbital lymphoma
Sharad Goyal1, Alan Cohler, Jayne Camporeale
1Department of Radiation Oncology, The Cancer Institute of New Jersey UMDNJ/Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903, USA. goyalsh@umdnj.edu
Radiation Medicine
|January 10, 2009
Summary
Intensity-modulated radiotherapy (IMRT) is a feasible treatment for rare orbital non-Hodgkin's lymphoma (NHL). This approach significantly reduces radiation dose to critical structures, offering excellent clinical outcomes with minimal toxicity.
Area of Science:
- Radiation Oncology
- Ophthalmology
- Oncology
Background:
- Orbital non-Hodgkin's lymphoma (NHL) is a rare condition, accounting for approximately 1% of all NHL cases.
- Treatment strategies for orbital lymphoma, particularly using advanced radiotherapy techniques, remain underexplored.
Observation:
- This study investigated the use of intensity-modulated radiotherapy (IMRT) in four patients diagnosed with orbital lymphoma.
- A comparative dosimetric analysis was conducted between IMRT and conventional radiotherapy (RT) using wedged pair fields.
Findings:
- All patients treated with IMRT achieved a complete response, with resolution of presenting symptoms and minimal side effects (Grade 1 dry eye and keratitis).
- IMRT significantly reduced radiation dose to the contralateral orbit, lacrimal gland, and lens compared to conventional RT (P < 0.01).
- IMRT also demonstrated significant reductions in the V5 and V10 parameters for the contralateral lens, orbit, lacrimal gland, and optic chiasm (P < 0.05).
Implications:
- Intensity-modulated radiotherapy (IMRT) is a viable and effective treatment modality for orbital lymphoma.
- IMRT provides excellent target volume coverage while sparing critical ocular structures, leading to favorable clinical outcomes and reduced toxicity.
- This study supports the adoption of IMRT for orbital lymphoma, offering a promising alternative to conventional radiotherapy with comparable efficacy and improved safety profile.
